Amica Mutual Insurance’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$115K Hold
14,350
0.01% 141
2026
Q1
$115K Hold
14,350
0.01% 142
2025
Q4
$167K Hold
14,350
0.01% 140
2025
Q3
$144K Hold
14,350
0.01% 141
2025
Q2
$250K Hold
14,350
0.02% 136
2025
Q1
$181K Hold
14,350
0.02% 135
2024
Q4
$151K Buy
+14,350
New +$201K 0.02% 135

Other funds holding SPRY

Amica Mutual Insurance's SPRY Position: Q2 2026 in Review

Amica Mutual Insurance held its ARS Pharmaceuticals (SPRY) position steady in Q2 2026 at 14,350 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #141.

Amica Mutual Insurance first reported a position in SPRY in Q4 2024 and has held it in 7 quarters since. The position peaked at $250K in Q2 2025. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Amica Mutual Insurance held 14,350 shares of ARS Pharmaceuticals worth $115K as of Q2 2026.
  • Amica Mutual Insurance left its ARS Pharmaceuticals share count unchanged in Q2 2026.
  • ARS Pharmaceuticals made up 0.01% of Amica Mutual Insurance's portfolio in Q2 2026, its #141 holding.
  • Amica Mutual Insurance first reported a position in ARS Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Amica Mutual Insurance's ARS Pharmaceuticals position peaked at $250K in Q2 2025.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Amica Mutual Insurance's 13F filing for Q2 2026, filed 5 Aug 2026.